戻る
Day One Biopharmaceuticals Inc (DAWN)価格
DAWN 株価推移チャート
DAWN 収入
Day One Biopharmaceuticals Inc
$10.16
-3.23%
$-0.33
終値： Jan 16, 16:00:00 GMT-5
$10.25
0.88%
$0.08
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$10.5
始値
$10.56
当日レンジ
$10.1 - $10.9
52週レンジ
$5.63 - $13.53
取引高
4.1M
平均取引高
2.7M
1株当たり利益(TTM)
-1.48
配当利回り
--
時価総額
$1.0B
DAWNとは何ですか？
Day One Biopharmaceuticals, Inc. operates as a holding company. The company is headquartered in Brisbane California, California and currently employs 184 full-time employees. The company went IPO on 2021-05-27. The firm partners with clinical oncologists, families, and scientists to identify, acquire, and develop cancer treatments. The Company’s commercial product, OJEMDA (tovorafenib), is an oral, brain-penetrant, selective type II rapidly accelerated fibrosarcoma (RAF) kinase inhibitor of mutant BRAF V600, wild-type BRAF, and wild-type CRAF kinases. Its pipeline product candidates include DAY301 and VRK1 program. The DAY301 candidate is a PTK7 targeted ADC composed of a novel humanized anti-PTK7 immunoglobulin G1 monoclonal antibody (mAb), conjugated with a topoisomerase I inhibitor through a stable and hydrophilic modified valine-alanine (VA) cleavable linker. Its VRK1 program is a novel target involved in the regulation of cell division and DNA damage repair.